Wed, Jun 08, 2016
The company will focus on dermatology as the fourth engine of growth for its OTC business, Sun Pharma said in a filing to the Bombay Stock Exchange (BSE).
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.